D. Jain

发表

Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype

Xiaoling Hu, T. Fan, R. Higashi, 2015, The Journal of Immunology.

D. Jain, Rahul Gosain, Y. Pollock, 2016, Current Oncology Reports.

Increasing Use of Elective Mastectomy and Contralateral Prophylactic Surgery Among Breast Conservation Candidates: A 14-year Report From a Comprehensive Cancer Center

S. Rai, Jianmin Pan, D. Jain, 2013, American journal of clinical oncology.

Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancer.

N. Dunlap, D. Jain, A. Quillo, 2015, Clinical breast cancer.

High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck.

S. Rai, N. Dunlap, D. Jain, 2016, Oral oncology.

Probable veno-occlusive disease after treatment with gemtuzumab ozogamicin in a patient with acute myeloid leukemia and a history of liver transplantation for familial hemochromatosis

J. Dutcher, D. Jain, P. Wiernik, 2003, Medical oncology.

Locoregional Recurrence in Patients With Triple-Negative Breast Cancer: Preliminary Results of a Single Institution Study

S. Rai, Jianmin Pan, D. Jain, 2011, American journal of clinical oncology.

A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction.

S. Rai, K. McMasters, W. Spanos, 2013, International journal of radiation oncology, biology, physics.

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

Gregory Riely, S. Temin, P. Ellis, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.

N. Hanna, Gregory Riely, L. Gaspar, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia by Bruton’s Tyrosine Kinase Inhibition

D. Jain, Ajoy Dias, 2013, Cardiovascular & hematological agents in medicinal chemistry.

First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.

S. Rai, K. McMasters, C. Scoggins, 2016, International journal of radiation oncology, biology, physics.

Dectin-1 Activation by a Natural Product

Xiaoling Hu, R. Higashi, A. N. Lane, 2015 .

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

Gregory Riely, S. Temin, P. Ellis, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

J. Callen, D. Jain, J. Malone, 2008, The Australasian journal of dermatology.

Leukaemia cutis in a patient treated for breast cancer

J. Callen, D. Jain, J. Malone, 2009, The Australasian journal of dermatology.

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.

N. Hanna, Gregory Riely, L. Gaspar, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update

M. Somerfield, L. Fallowfield, H. Rugo, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of immunotherapy toxicities in older adults.

D. Jain, S. Bhandari, C. Perez, 2018, Seminars in oncology.

Human epidermal growth factor antagonists and cardiotoxicity-A short review of the problem and preventative measures.

D. Jain, W. Claudino, C. Perez, 2016, Critical reviews in oncology/hematology.

Delay of Adjuvant Chemotherapy After Elective Mastectomy and Immediate Reconstruction in Breast-conservation Candidates: A Matched-pair Analysis

S. Rai, Jianmin Pan, J. Crew, 2014, American journal of clinical oncology.

Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin

Richard Talusan, D. Jain, P. Wiernik, 2002, Medical oncology.

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3

Nofisat Ismaila, I. Jaiyesimi, Navneet Singh, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study

S. Rai, D. Jain, M. Mandadi, 2019, Breast Cancer Research and Treatment.

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3

Nofisat Ismaila, I. Jaiyesimi, Navneet Singh, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2

Gregory Riely, S. Temin, P. Ellis, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2

Erin L. Schenk, Nofisat Ismaila, L. Sequist, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.